Pricing Log in Create free account

Cadrenal Therapeutics, Inc. (CVKD) vs Dermata Therapeutics, Inc. (DRMA)

Cadrenal Therapeutics, Inc. and Dermata Therapeutics, Inc. are both Biotechnology companies. Cadrenal Therapeutics, Inc. and Dermata Therapeutics, Inc. are of similar size ($3.8M and $3.6M). Across the 9 metrics below, Dermata Therapeutics, Inc. leads on 5 and Cadrenal Therapeutics, Inc. on 4.

Valuation

Metric CVKD DRMA Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B 0.74 0.89 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m 0.07 0.66
EV/Sales n/m n/m 9.02
Earnings yield (471.15%) (585.53%) (32.88%)
Free cash flow yield (335.44%) (259.42%) (23.13%)

Profitability

Metric CVKD DRMA Biotechnology median
Gross margin 0.00% — 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (275.16%) (183.89%) (51.96%)
Return on assets (199.59%) (139.93%) (46.06%)
Return on invested capital (427.54%) 0.00% 0.00%

Growth

Metric CVKD DRMA Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 23.94% 89.84% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric CVKD DRMA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.73 2.81 4.97
Net debt to EBITDA 0.30 0.97 1.01

Dividend

Metric CVKD DRMA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CVKD DRMA Biotechnology median
Market cap 3.57m 3.78m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack